Curated News
By: NewsRamp Editorial Staff
November 21, 2024
ioTech International Releases ioRinse™ MR for Cancer Patients
Discuss on Reddit
LinkedIn
Substack
Telegram
GithubTLDR
- Gain advantage in cancer treatment relief with ioRinse™ MR, providing immediate and lasting relief from oral side effects of chemotherapy and radiation.
- Leverages ioTech’s proprietary molecular iodine technology to address oral health challenges caused by chemotherapy and radiation, providing relief from mouth sores, dry mouth, oral pain, and ulcers.
- ioRinse™ MR offers transformative relief, enabling cancer patients to resume daily activities by managing the painful side effects of chemotherapy and radiation, enhancing their quality of life.
- Jackie Strauss, a breast cancer survivor, found instant relief from oral mucositis and lesions after using ioRinse™ MR, demonstrating its breakthrough effectiveness.
Impact - Why it Matters
This news matters as it introduces a product that can provide substantial relief for cancer patients suffering from debilitating side effects of chemotherapy and radiation, improving their quality of life and overall comfort. Additionally, the company is offering a free starter supply of ioRinse™ MR to oncology patients, addressing the cost burden of managing these oral mucositis symptoms.
Summary
ioTech International has released ioRinse™ MR, an advanced oral rinse designed to provide relief for cancer patients suffering from mouth sores, dry mouth, oral pain, and ulcers resulting from chemotherapy and radiation. Leveraging ioTech’s proprietary molecular iodine technology, ioRinse™ MR offers immediate, lasting relief without causing tooth staining. The company is also enrolling oncology offices to provide a free starter supply of ioRinse™ MR to patients beginning active therapy.
Source Statement
This curated news summary relied on this press release disributed by Newsworthy.ai. Read the source press release here, ioTech International Releases ioRinse™ MR for Cancer Patients
